Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).

作者信息

Blasi F

机构信息

Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore di Milano, Italy.

出版信息

J Chemother. 2004 Apr;16 Suppl 2:11-4. doi: 10.1080/1120009x.2004.11782367.

DOI:10.1080/1120009x.2004.11782367

PMID:15255556

Abstract

摘要

相似文献

Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).

J Chemother. 2004 Apr;16 Suppl 2:11-4. doi: 10.1080/1120009x.2004.11782367.

Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients.

J Chemother. 2004 Apr;16 Suppl 2:8-10. doi: 10.1080/1120009x.2004.11782366.

The use of levofloxacin in the treatment of respiratory tract infection.

J Chemother. 2000 Oct;12 Suppl 4:27-31. doi: 10.1080/1120009x.2000.11782310.

[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].

Antibiot Khimioter. 2001;46(7):38-46.

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.

Curr Med Res Opin. 2008 May;24(5):1279-84. doi: 10.1185/030079908x280400. Epub 2008 Mar 20.

[Levofloxacin in the treatment of respiratory infections].

Antibiot Khimioter. 2002;47(8):32-42.

Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.

Diagn Microbiol Infect Dis. 2002 Sep;44(1):127-8. doi: 10.1016/s0732-8893(02)00450-9.

Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.

J Chemother. 2004 Apr;16 Suppl 2:15-7.

Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.

J Infect Chemother. 2009 Oct;15(5):301-11. doi: 10.1007/s10156-009-0713-9. Epub 2009 Oct 24.

Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).

Diagn Microbiol Infect Dis. 2002 Sep;44(1):65-7. doi: 10.1016/s0732-8893(02)00444-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验